120 related articles for article (PubMed ID: 17895068)
1. Assessment scales for the evaluation of stroke patients.
Lyden PD; Hantson L
J Stroke Cerebrovasc Dis; 1998; 7(2):113-27. PubMed ID: 17895068
[TBL] [Abstract][Full Text] [Related]
2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
3. A comparison of five stroke scales with measures of disability, handicap, and quality of life.
De Haan R; Horn J; Limburg M; Van Der Meulen J; Bossuyt P
Stroke; 1993 Aug; 24(8):1178-81. PubMed ID: 8342193
[TBL] [Abstract][Full Text] [Related]
4. Interdependence of stroke outcome scales: reliable estimates from the Virtual International Stroke Trials Archive (VISTA).
Goldie FC; Fulton RL; Frank B; Lees KR;
Int J Stroke; 2014 Apr; 9(3):328-32. PubMed ID: 24206445
[TBL] [Abstract][Full Text] [Related]
5. Clinical interpretation and use of stroke scales.
Kasner SE
Lancet Neurol; 2006 Jul; 5(7):603-12. PubMed ID: 16781990
[TBL] [Abstract][Full Text] [Related]
6. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
8. Longer term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?
Wilkinson PR; Wolfe CD; Warburton FG; Rudd AG; Howard RS; Ross-Russell RW; Beech R
Qual Health Care; 1997 Sep; 6(3):125-30. PubMed ID: 10173769
[TBL] [Abstract][Full Text] [Related]
9. Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136.
van Straten A; de Haan RJ; Limburg M; van den Bos GA
Stroke; 2000 Nov; 31(11):2610-5. PubMed ID: 11062283
[TBL] [Abstract][Full Text] [Related]
10. Interconversion of stroke scales. Implications for therapeutic trials.
Muir KW; Grosset DG; Lees KR
Stroke; 1994 Jul; 25(7):1366-70. PubMed ID: 8023351
[TBL] [Abstract][Full Text] [Related]
11. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
12. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
13. Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review.
Balu S
Curr Med Res Opin; 2009 Jun; 25(6):1329-41. PubMed ID: 19419341
[TBL] [Abstract][Full Text] [Related]
14. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
[TBL] [Abstract][Full Text] [Related]
15. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
Bruno A; Saha C; Williams LS
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
[TBL] [Abstract][Full Text] [Related]
16. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
17. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial.
Palesch YY; Yeatts SD; Tomsick TA; Foster LD; Demchuk AM; Khatri P; Hill MD; Jauch EC; Jovin TG; Yan B; von Kummer R; Molina CA; Goyal M; Schonewille WJ; Mazighi M; Engelter ST; Anderson C; Spilker J; Carrozzella J; Ryckborst KJ; Janis LS; Simpson A; Simpson KN; Broderick JP;
Stroke; 2015 May; 46(5):1321-7. PubMed ID: 25858239
[TBL] [Abstract][Full Text] [Related]
18. A simple risk index and thrombolytic treatment response in acute ischemic stroke.
Ovbiagele B; Reeves MJ; Nasiri M; Johnston SC; Bath PM; Saposnik G;
JAMA Neurol; 2014 Jul; 71(7):848-54. PubMed ID: 24798141
[TBL] [Abstract][Full Text] [Related]
19. A radiologist's guide to the clinical scales used in the 2015 Endovascular Stroke Trials and the Revised American Heart Association/American Stroke Association Guidelines for Endovascular Stroke Treatment.
Scheinfeld MH; Erdfarb AJ; Krieger DA; Bhupali D; Zampolin RL
Emerg Radiol; 2016 Oct; 23(5):497-501. PubMed ID: 27389543
[TBL] [Abstract][Full Text] [Related]
20. Assessment scales in stroke: clinimetric and clinical considerations.
Harrison JK; McArthur KS; Quinn TJ
Clin Interv Aging; 2013; 8():201-11. PubMed ID: 23440256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
